Effects of Extracorporeal Treatment in Patients With Acute Poisoning

This study aims to estimate the effect of extracorporeal treatments (ECTRs) on 28-day survival in patients with acute poisoning. The treatment strategy was receipt of ECTR (hemoperfusion, hemodialysis, continuous kidney replacement therapy, and/or or plasma exchange) versus a non-ECTR strategy.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Poisoning Chemically-Induced Disorders Extracorporeal Treatment

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, 210008, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

12 years of age and older
History of acute poisoning

Exclusion criteria

missing records in survival outcome

Treatment and study plan

extracorporeal treatment

Procedure

Extracorporeal treatments include hemoperfusion, hemodialysis, continuous kidney replacement therapy, and plasma exchange.

Primary outcomes

Survival outcome

Time frame: 28 days within the index date of presentation at emergency department

Sponsors and collaborators

Lead sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Other

Registry information

Official study title

Effects of Extracorporeal Treatment in Patients With Acute Poisoning in Jiangsu Province, China: A Multi-center Target Trial Emulation

Important dates

Study start: 2015
Primary completion: 2023
Study completion: 2026
First posted: Jan 29, 2025
Registry last updated: Dec 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting